(Q34851412)

4 August 2017

1 reference

title

Radiofrequency ablation of unresectable liver metastases (English)

1 reference

4 August 2017

Jerome Seidenfeld

1

1 reference

4 August 2017

Allen Korn

series ordinal

2

1 reference

4 August 2017

Naomi Aronson

series ordinal

3

1 reference

4 August 2017

publication date

1 September 2002

1 reference

Journal of the American College of Surgeons

4 August 2017

published in

1 reference

4 August 2017

volume

195

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

378-386

1 reference

4 August 2017

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Management of hepatic metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Therapeutic alternatives in metastatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Natural history of patients with untreated liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Resection of hepatic metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Surgical therapy of hepatic colorectal metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Current treatment for colorectal cancer metastatic to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Locoregional treatments for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Surgical treatment of malignant liver tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Management strategies for colorectal liver metastases--Part II.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Local ablation therapy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

An appraisal of percutaneous treatment of liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Percutaneous ultrasound-guided radiofrequency ablation of liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Non-surgical treatment for liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Radiofrequency thermal ablation of liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

New trends in the surgical treatment of colorectal cancer liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Radiofrequency ablation of unresectable primary liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Percutaneous radiofrequency thermal ablation for liver tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2802%2901247-4

7 January 2021

10.1016/S1072-7515(02)01247-4

Identifiers

DOI

1 reference

4 August 2017

1 reference